Popular artificial sweetener linked to heart attack and stroke

Written By :  Dr. Kamal Kant Kohli
Published On 2023-02-28 14:30 GMT   |   Update On 2023-02-28 15:18 GMT

USA: A recent study published in Nature Medicine has shown that a popular artificial sweetener, erythritol, may up the risk of stroke and heart attack.A study of over 4,000 people in the U.S. and Europe found that erythritol is associated with incident MACE (major adverse cardiac events) risk and fosters enhanced thrombosis. MACE includes stroke, heart attack or death. The researchers...

Login or Register to read the full article

USA: A recent study published in Nature Medicine has shown that a popular artificial sweetener, erythritol, may up the risk of stroke and heart attack.

A study of over 4,000 people in the U.S. and Europe found that erythritol is associated with incident MACE (major adverse cardiac events) risk and fosters enhanced thrombosis. MACE includes stroke, heart attack or death.

The researchers also examined the effects of adding erythritol to either whole blood or isolated platelets, which are cell fragments that clump together to stop bleeding and contribute to blood clots. Results revealed that erythritol made platelets easier to activate and form a clot. Pre-clinical studies confirmed ingestion of erythritol heightened clot formation.

“Sweeteners like erythritol have rapidly increased in popularity in recent years, but there needs to be more in-depth research into their long-term effects,” said senior author Stanley Hazen, M.D., Ph.D., chairman for the Department of Cardiovascular & Metabolic Sciences in Lerner Research Institute and co-section head of Preventive Cardiology at Cleveland Clinic. “Cardiovascular disease builds over time, and heart disease is the leading cause of death globally. We need to ensure our food isn’t hidden, contributors.”

Artificial sweeteners, such as erythritol, are common replacements for table sugar in low-calorie, low-carbohydrate and “keto” products. Sugar-free products containing erythritol are often recommended for people who have obesity, diabetes or metabolic syndrome and are looking for options to help manage their sugar or calorie intake. People with these conditions also are at higher risk for adverse cardiovascular events like heart attack and stroke.

Erythritol is about 70% as sweet as sugar and is produced through fermenting corn. After ingestion, erythritol is poorly metabolized by the body. Instead, it goes into the bloodstream and leaves the body mainly through urine. The human body creates low amounts of erythritol naturally, so any additional consumption can accumulate.

Measuring artificial sweeteners is difficult and labeling requirements are minimal, and often do not list individual compounds. Erythritol is “Generally Recognized As Safe (GRAS)” by the FDA, which means there is no requirement for long-term safety studies.

The authors note the importance of follow-up studies to confirm their findings in the general population. The study had several limitations, including that clinical observation studies demonstrate association and not causation.

“Our study shows that when participants consumed an artificially sweetened beverage with an amount of erythritol found in many processed foods, markedly elevated levels in the blood are observed for days well above those observed to enhance clotting risks,” said Dr. Hazen. “Further safety studies must be conducted to examine the long-term effects of artificial sweeteners in general, and erythritol specifically, on heart attack and stroke risks, particularly in people at higher risk for cardiovascular disease.”

Authors recommend talking to your doctor or a certified dietician to learn more about healthy food choices and for personalized recommendations. 

Reference:

Witkowski, M., Nemet, I., Alamri, H. et al. The artificial sweetener erythritol and cardiovascular event risk. Nat Med (2023). https://doi.org/10.1038/s41591-023-02223-9


Tags:    
Article Source : Nature Medicine

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News